Skip to main content
Erschienen in:

15.04.2021 | Original Article

CHOP Increases TRIB3-Dependent miR-208 Expression to Potentiate Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating TIMP3 in Atherosclerosis

verfasst von: Rui Chen, Yan Zhang, Chunyan Zhao

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

C/EBP homologous protein (CHOP) has been identified as a suitable therapeutic target to combat atherosclerosis but the mechanism has not been fully studied. Here, we sought to define the role and underlying mechanism of CHOP in atherosclerosis.

Methods

Mouse models of atherosclerosis in ApoE-/- mice were established by high-fat feeding, where miR-208 expression was determined. Then atherosclerotic plaque tissues were isolated from the model mice. Loss- and gain-function assays were performed on trypsinized vascular smooth muscle cells (VSMCs) to test the in vitro effect of CHOP in controlling the tribbles homologue 3 (TRIB3)/microRNA-208 (miR-208)/tissue inhibitor of metalloproteinases-3 (TIMP3) axis in atherosclerosis by determining cell proliferation and migration as well as blood lipid levels. Moreover, expression of α-smooth muscle actin (α-SMA) and type I collagen expression was determined using immunofluorescence staining to assess plaque stability in mice.

Results

miR-208 expression was elevated in atherosclerosis samples and miR-208 overexpression promoted proliferation and migration of VSMCs but diminished plaque stability in mice. TIMP3 was targeted by miR-208, which could be abrogated by upregulation of TIMP3. In addition, CHOP increased TRIB3 expression to upregulate miR-208 and to downregulate TIMP3, which potentiated VSMC proliferation and migration in vitro and in vivo.

Conclusion

Taken together, inhibition of CHOP may inhibit the proliferation and migration of VSMCs as well as reduce the levels of TC, TG, and LDL-C but increase the level of HDL-C through the TRIB3/miR-208/TIMP3 axis, thereby inhibiting the progression of atherosclerosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol. Med. 2017;23:332–47.PubMedCrossRef Khyzha N, Alizada A, Wilson MD, Fish JE. Epigenetics of atherosclerosis: emerging mechanisms and methods. Trends Mol. Med. 2017;23:332–47.PubMedCrossRef
3.
Zurück zum Zitat Zhang BC, Li XK, Che WL, Li WM, Hou L, Wei YD, et al. Peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41:143–9.PubMed Zhang BC, Li XK, Che WL, Li WM, Hou L, Wei YD, et al. Peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41:143–9.PubMed
4.
Zurück zum Zitat Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.PubMedCrossRef Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.PubMedCrossRef
7.
Zurück zum Zitat Zeng Y, Song JX, Shen XC. Herbal remedies supply a novel prospect for the treatment of atherosclerosis: a review of current mechanism studies. Phytother. Res. 2012;26:159–67.PubMedCrossRef Zeng Y, Song JX, Shen XC. Herbal remedies supply a novel prospect for the treatment of atherosclerosis: a review of current mechanism studies. Phytother. Res. 2012;26:159–67.PubMedCrossRef
8.
Zurück zum Zitat Dong Y, Fernandes C, Liu Y, Wu Y, Wu H, Brophy ML, et al. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis. Diab. Vasc. Dis. Res. 2017;14:14–23.PubMedCrossRef Dong Y, Fernandes C, Liu Y, Wu Y, Wu H, Brophy ML, et al. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis. Diab. Vasc. Dis. Res. 2017;14:14–23.PubMedCrossRef
9.
Zurück zum Zitat Goodall JCWC, Zhang Y. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc. Natl. Acad. Sci. U. S. A. 2010;107:17698–703.PubMedPubMedCentralCrossRef Goodall JCWC, Zhang Y. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc. Natl. Acad. Sci. U. S. A. 2010;107:17698–703.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat H N. CHOP is a multifunctional transcription factor in the ER stress response. J Biochem. 2012;151:217-9. H N. CHOP is a multifunctional transcription factor in the ER stress response. J Biochem. 2012;151:217-9.
11.
Zurück zum Zitat Ohoka NYS, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 2005;24:1243–55.PubMedPubMedCentralCrossRef Ohoka NYS, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 2005;24:1243–55.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Wang ZHSY, Zhang S. Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice. Diabetes. 2012;61:463–73.PubMedPubMedCentralCrossRef Wang ZHSY, Zhang S. Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice. Diabetes. 2012;61:463–73.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat An D, Lessard SJ, Toyoda T, Lee MY, Koh HJ, Qi L, et al. Overexpression of TRB3 in muscle alters muscle fiber type and improves exercise capacity in mice. Am. J. Phys. Regul. Integr. Comp. Phys. 2014;306:R925–33. An D, Lessard SJ, Toyoda T, Lee MY, Koh HJ, Qi L, et al. Overexpression of TRB3 in muscle alters muscle fiber type and improves exercise capacity in mice. Am. J. Phys. Regul. Integr. Comp. Phys. 2014;306:R925–33.
15.
Zurück zum Zitat OA CDA, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxford). 2015;214:33–50.CrossRef OA CDA, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxford). 2015;214:33–50.CrossRef
16.
Zurück zum Zitat Di Gregoli KMAN, Bianco R. MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin. Circ. Res. 2017;120:49–65.PubMedPubMedCentralCrossRef Di Gregoli KMAN, Bianco R. MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin. Circ. Res. 2017;120:49–65.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J, et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation. 2013;127:386–96.PubMedCrossRef Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J, et al. Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation. 2013;127:386–96.PubMedCrossRef
18.
Zurück zum Zitat Goikuria H, Freijo MDM, Vega Manrique R, Sastre M, Elizagaray E, Lorenzo A, et al. Characterization of carotid smooth muscle cells during phenotypic transition. Cells. 2018;7. Goikuria H, Freijo MDM, Vega Manrique R, Sastre M, Elizagaray E, Lorenzo A, et al. Characterization of carotid smooth muscle cells during phenotypic transition. Cells. 2018;7.
19.
Zurück zum Zitat Jiang LQY, Wang Z, Ma X, Wang H, Li J. Inhibition of microRNA-103 attenuates inflammation and endoplasmic reticulum stress in atherosclerosis through disrupting the PTEN-mediated MAPK signaling. J. Cell. Physiol. 2020;235:380–93.PubMedCrossRef Jiang LQY, Wang Z, Ma X, Wang H, Li J. Inhibition of microRNA-103 attenuates inflammation and endoplasmic reticulum stress in atherosclerosis through disrupting the PTEN-mediated MAPK signaling. J. Cell. Physiol. 2020;235:380–93.PubMedCrossRef
20.
Zurück zum Zitat Huang SC, Wang M, Wu WB, Wang R, Cui J, Li W, et al. Mir-22-3p inhibits arterial smooth muscle cell proliferation and migration and neointimal hyperplasia by targeting HMGB1 in arteriosclerosis obliterans. Cell. Physiol. Biochem. 2017;42:2492–506.PubMedCrossRef Huang SC, Wang M, Wu WB, Wang R, Cui J, Li W, et al. Mir-22-3p inhibits arterial smooth muscle cell proliferation and migration and neointimal hyperplasia by targeting HMGB1 in arteriosclerosis obliterans. Cell. Physiol. Biochem. 2017;42:2492–506.PubMedCrossRef
21.
Zurück zum Zitat Wang JPY, Zhong Y, Jiang S, Shao J, Gong J. Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease. PLoS One. 2014;9:e107012.PubMedPubMedCentralCrossRef Wang JPY, Zhong Y, Jiang S, Shao J, Gong J. Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease. PLoS One. 2014;9:e107012.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Cardellini MMR, Martelli E. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 2009;58:2396–401.PubMedPubMedCentralCrossRef Cardellini MMR, Martelli E. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 2009;58:2396–401.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology. 2009;136:663–72 e4.PubMedCrossRef Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology. 2009;136:663–72 e4.PubMedCrossRef
24.
Zurück zum Zitat Stohr R, Kappel BA, Carnevale D, Cavalera M, Mavilio M, Arisi I, et al. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Mol Metab. 2015;4:741–52.PubMedPubMedCentralCrossRef Stohr R, Kappel BA, Carnevale D, Cavalera M, Mavilio M, Arisi I, et al. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Mol Metab. 2015;4:741–52.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Liu P, Su J, Song X, Wang S. miR-92a regulates the expression levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 3 via sirtuin 1 signaling in hydrogen peroxide-induced vascular smooth muscle cells. Mol Med Rep. 2018;17:1041–8.PubMed Liu P, Su J, Song X, Wang S. miR-92a regulates the expression levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 3 via sirtuin 1 signaling in hydrogen peroxide-induced vascular smooth muscle cells. Mol Med Rep. 2018;17:1041–8.PubMed
26.
Zurück zum Zitat English WR, Ireland-Zecchini H, Baker AH, Littlewood TD, Bennett MR, Murphy G. Tissue inhibitor of metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells. PLoS One. 2018;13:e0195116.PubMedPubMedCentralCrossRef English WR, Ireland-Zecchini H, Baker AH, Littlewood TD, Bennett MR, Murphy G. Tissue inhibitor of metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells. PLoS One. 2018;13:e0195116.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Xu Y, Bei Y, Shen S, Zhang J, Lu Y, Xiao J, et al. MicroRNA-222 Promotes the proliferation of pulmonary arterial smooth muscle cells by targeting P27 and TIMP3. Cell. Physiol. Biochem. 2017;43:282–92.PubMedCrossRef Xu Y, Bei Y, Shen S, Zhang J, Lu Y, Xiao J, et al. MicroRNA-222 Promotes the proliferation of pulmonary arterial smooth muscle cells by targeting P27 and TIMP3. Cell. Physiol. Biochem. 2017;43:282–92.PubMedCrossRef
29.
Zurück zum Zitat Churov A, Summerhill V, Grechko A, Orekhova V, Orekhov A. MicroRNAs as Potential Biomarkers in Atherosclerosis. Int J Mol Sci. 2019;20:5547.PubMedCentralCrossRef Churov A, Summerhill V, Grechko A, Orekhova V, Orekhov A. MicroRNAs as Potential Biomarkers in Atherosclerosis. Int J Mol Sci. 2019;20:5547.PubMedCentralCrossRef
30.
Zurück zum Zitat Papageorgiou N, Tousoulis D, Androulakis E, Kontogeorgou A, Charakida M, Giolis A, et al. The role of microRNAs in the initiation and progression of stable atheromatous plaque. Curr. Pharm. Des. 2013;19:1651–7.PubMed Papageorgiou N, Tousoulis D, Androulakis E, Kontogeorgou A, Charakida M, Giolis A, et al. The role of microRNAs in the initiation and progression of stable atheromatous plaque. Curr. Pharm. Des. 2013;19:1651–7.PubMed
31.
Zurück zum Zitat Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 2012;122:4190–202.PubMedPubMedCentralCrossRef Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 2012;122:4190–202.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Horie TBO, Kuwabara Y. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J. Am. Heart Assoc. 2012;1:e003376.PubMedPubMedCentralCrossRef Horie TBO, Kuwabara Y. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice. J. Am. Heart Assoc. 2012;1:e003376.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Zhang Y, Wang Y, Wang X, Zhang Y, Eisner GM, Asico LD, et al. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J. Hypertens. 2011;29:1560–8.PubMedCrossRef Zhang Y, Wang Y, Wang X, Zhang Y, Eisner GM, Asico LD, et al. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J. Hypertens. 2011;29:1560–8.PubMedCrossRef
35.
Zurück zum Zitat Fu X, Zeng L, Liu Z, Ke X, Lei L, Li G. MicroRNA-206 regulates the secretion of inflammatory cytokines and MMP9 expression by targeting TIMP3 in Mycobacterium tuberculosis-infected THP-1 human macrophages. Biochem. Biophys. Res. Commun. 2016;477:167–73.PubMedCrossRef Fu X, Zeng L, Liu Z, Ke X, Lei L, Li G. MicroRNA-206 regulates the secretion of inflammatory cytokines and MMP9 expression by targeting TIMP3 in Mycobacterium tuberculosis-infected THP-1 human macrophages. Biochem. Biophys. Res. Commun. 2016;477:167–73.PubMedCrossRef
36.
Zurück zum Zitat Di Gregoli K, Mohamad Anuar NN, Bianco R, White SJ, Newby AC, George SJ, et al. MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin. Circ. Res. 2017;120:49–65.PubMedPubMedCentralCrossRef Di Gregoli K, Mohamad Anuar NN, Bianco R, White SJ, Newby AC, George SJ, et al. MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin. Circ. Res. 2017;120:49–65.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 2009;58:2396–401.PubMedPubMedCentralCrossRef Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes. 2009;58:2396–401.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Son DJJY, Seo YS. Interleukin-32alpha inhibits endothelial inflammation, vascular smooth muscle cell activation, and atherosclerosis by upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis. Theranostics. 2017;7:2186–203.PubMedPubMedCentralCrossRef Son DJJY, Seo YS. Interleukin-32alpha inhibits endothelial inflammation, vascular smooth muscle cell activation, and atherosclerosis by upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis. Theranostics. 2017;7:2186–203.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Zhai H, Qi X, Li Z, Zhang W, Li C, Ji L, et al. TIMP3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP2 and MMP9 activity, and reduced TNFalpha expression. Mol. Med. Rep. 2018;18:2061–7.PubMedPubMedCentral Zhai H, Qi X, Li Z, Zhang W, Li C, Ji L, et al. TIMP3 suppresses the proliferation and migration of SMCs from the aortic neck of atherosclerotic AAA in rabbits, via decreased MMP2 and MMP9 activity, and reduced TNFalpha expression. Mol. Med. Rep. 2018;18:2061–7.PubMedPubMedCentral
41.
Zurück zum Zitat Stohr R, Cavalera M, Menini S, Mavilio M, Casagrande V, Rossi C, et al. Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice. Atherosclerosis. 2014;235:438–43.PubMedCrossRef Stohr R, Cavalera M, Menini S, Mavilio M, Casagrande V, Rossi C, et al. Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice. Atherosclerosis. 2014;235:438–43.PubMedCrossRef
42.
Zurück zum Zitat Hong B, Zhou J, Ma K, Zhang J, Xie H, Zhang K, et al. TRIB3 Promotes the proliferation and invasion of renal cell carcinoma cells via activating MAPK signaling pathway. Int. J. Biol. Sci. 2019;15:587–97.PubMedPubMedCentralCrossRef Hong B, Zhou J, Ma K, Zhang J, Xie H, Zhang K, et al. TRIB3 Promotes the proliferation and invasion of renal cell carcinoma cells via activating MAPK signaling pathway. Int. J. Biol. Sci. 2019;15:587–97.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Ding CZ, Guo XF, Wang GL, Wang HT, Xu GH, Liu YY, et al. High glucose contributes to the proliferation and migration of non-small cell lung cancer cells via GAS5-TRIB3 axis. Biosci. Rep. 2018;38. Ding CZ, Guo XF, Wang GL, Wang HT, Xu GH, Liu YY, et al. High glucose contributes to the proliferation and migration of non-small cell lung cancer cells via GAS5-TRIB3 axis. Biosci. Rep. 2018;38.
44.
Zurück zum Zitat Ma BZH, Wang Y. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. J. Exp. Clin. Cancer Res. 2018;37:210.PubMedPubMedCentralCrossRef Ma BZH, Wang Y. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. J. Exp. Clin. Cancer Res. 2018;37:210.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Bi SJWC, Zhang J, Lv ZP, Li YX. Atorvastatin up-regulates TRIB3 independent of ATF4-CHOP pathway in atherosclerotic patients. Int. J. Clin. Exp. Med. 2015;8:21635–40.PubMedPubMedCentral Bi SJWC, Zhang J, Lv ZP, Li YX. Atorvastatin up-regulates TRIB3 independent of ATF4-CHOP pathway in atherosclerotic patients. Int. J. Clin. Exp. Med. 2015;8:21635–40.PubMedPubMedCentral
46.
Zurück zum Zitat Wang SZM, Liu Z. Relationship between CHOP/GADD153 and unstable human carotid atherosclerotic plaque. Br. J. Neurosurg. 2017;31:648–52.PubMedCrossRef Wang SZM, Liu Z. Relationship between CHOP/GADD153 and unstable human carotid atherosclerotic plaque. Br. J. Neurosurg. 2017;31:648–52.PubMedCrossRef
47.
Zurück zum Zitat Zhou AXWX, Lin CS. C/EBP-homologous protein (CHOP) in vascular smooth muscle cells regulates their proliferation in aortic explants and atherosclerotic lesions. Circ. Res. 2015;116:1736–43.PubMedPubMedCentralCrossRef Zhou AXWX, Lin CS. C/EBP-homologous protein (CHOP) in vascular smooth muscle cells regulates their proliferation in aortic explants and atherosclerotic lesions. Circ. Res. 2015;116:1736–43.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Uchida MSS, Suzuki T, Ishii I. p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs. Microvasc. Res. 2016;103:36–40.PubMedCrossRef Uchida MSS, Suzuki T, Ishii I. p27(Kip1) and p21(Cip1)-independent proliferative inhibition of vascular smooth muscle cells cultured in type-I collagen matrix honeycombs. Microvasc. Res. 2016;103:36–40.PubMedCrossRef
Metadaten
Titel
CHOP Increases TRIB3-Dependent miR-208 Expression to Potentiate Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating TIMP3 in Atherosclerosis
verfasst von
Rui Chen
Yan Zhang
Chunyan Zhao
Publikationsdatum
15.04.2021
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 4/2022
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-021-07154-6

Weitere Artikel der Ausgabe 4/2022

Cardiovascular Drugs and Therapy 4/2022 Zur Ausgabe

Neu im Fachgebiet Kardiologie

Nach dem Nitrospray fünf Minuten mit der Kardio-CT warten!

19.07.2024 Koronare Herzerkrankung Nachrichten

Nach Verabreichung von sublingualem Nitrospray vor einer CT-Koronarangiografie sollte man unbedingt die in Leitlinien empfohlene Wartezeit einhalten, rät ein kardiologisches Team aus Belgien.

Welche Antikoagulation bei Vorhofflimmern und Leberzirrhose?

19.07.2024 Leberzirrhose Nachrichten

Bei einer Auswertung von US-Versicherungsdaten ging es um die Frage, welche Antikoagulation –  Apixaban, Rivaroxaban oder Warfarin – bei Personen mit Leberzirrhose und Vorhofflimmern unterm Strich die beste Prophylaxe-Option ist.     

Mehrgefäßstenosen einzeitig oder zweizeitig eröffnen?

18.07.2024 Gefäßstenosen Nachrichten

Nach einem Herzinfarkt mit Mehrgefäßerkrankung sind bessere Ergebnisse zu erwarten, wenn alle stenotischen Abschnitte revaskularisiert werden. Sollte das in einer oder in mehreren Sitzungen geschehen? Eine Metaanalyse gibt eine klare Antwort.

Erste zielgerichtete Therapie zur Behandlung der hypertrophen obstruktiven Kardiomyopathie

18.07.2024 Kardiomyopathie Nachrichten

Mit Mavacamten von Bristol Myers Squibb ist erstmals eine zielgerichtete Therapie der hypertrophen obstruktiven Kardiomyopathie (HOCM) verfügbar. Der Myosin-Inhibitor verhindert die bei HOCM übermäßige Bildung von Aktin-Myosin-Querbrücken und verbessert die Symptomatik und die Lebensqualität von Betroffenen.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.